These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27616279)

  • 21. Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests.
    Maghnie M; Uga E; Temporini F; Di Iorgi N; Secco A; Tinelli C; Papalia A; Casini MR; Loche S
    Eur J Endocrinol; 2005 May; 152(5):735-41. PubMed ID: 15879359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New Diagnostic Cutoffs for Adrenal Insufficiency After Cosyntropin Stimulation Using Abbott Architect Cortisol Immunoassay.
    Zha L; Li J; Krishnan SM; Brennan MR; Zhang YV; Povse P; Kerlin R; Shively K; Oleksik F; Williams J; Sykes E; Sun Q
    Endocr Pract; 2022 Jul; 28(7):684-689. PubMed ID: 35487459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of morning serum cortisol level after transsphenoidal resection of pituitary adenoma to predict the need for long-term glucocorticoid supplementation.
    Marko NF; Gonugunta VA; Hamrahian AH; Usmani A; Mayberg MR; Weil RJ
    J Neurosurg; 2009 Sep; 111(3):540-4. PubMed ID: 19326985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease.
    Abdu TA; Elhadd TA; Neary R; Clayton RN
    J Clin Endocrinol Metab; 1999 Mar; 84(3):838-43. PubMed ID: 10084558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical insights into the safety and utility of the insulin tolerance test (ITT) in the assessment of the hypothalamo-pituitary-adrenal axis.
    Finucane FM; Liew A; Thornton E; Rogers B; Tormey W; Agha A
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):603-7. PubMed ID: 18346212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "A morning cortisol is the most effective clinical predictor of short synacthen test outcome": A tertiary care centre experience.
    Mathara Diddhenipothage SAD; Beck KJ; Loo H; Amiyangoda GK; Pofi R; Tomlinson JW; Pal A
    Clin Endocrinol (Oxf); 2023 Aug; 99(2):142-151. PubMed ID: 37288515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypothalamus-pituitary dysfunction is common in patients with stable cirrhosis and abnormal low dose synacthen test.
    Fede G; Spadaro L; Privitera G; Tomaselli T; Bouloux PM; Purrello F; Burroughs AK
    Dig Liver Dis; 2015 Dec; 47(12):1047-51. PubMed ID: 26364559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term basal and dynamic evaluation of hypothalamic-pituitary-adrenal (HPA) axis in acromegalic patients.
    Ronchi CL; Ferrante E; Rizzo E; Giavoli C; Verrua E; Bergamaschi S; Lania AG; Beck-Peccoz P; Spada A
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):608-12. PubMed ID: 18410544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of adrenal function using the human corticotrophin-releasing hormone test, low dose Synacthen test and 9am cortisol level in children and adolescents with central adrenal insufficiency.
    Maguire AM; Biesheuvel CJ; Ambler GR; Moore B; McLean M; Cowell CT
    Clin Endocrinol (Oxf); 2008 May; 68(5):683-91. PubMed ID: 18070143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do we need 30 min cortisol measurement in the short synacthen test: a retrospective study.
    Kumar R; Carr P; Moore K; Rajput Z; Ward L; Wassif WS
    Postgrad Med J; 2020 Aug; 96(1138):467-472. PubMed ID: 31810992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can basal cortisol measurement be an alternative to the insulin tolerance test in the assessment of the hypothalamic-pituitary-adrenal axis before and after pituitary surgery?
    Karaca Z; Tanriverdi F; Atmaca H; Gokce C; Elbuken G; Selcuklu A; Unluhizarci K; Kelestimur F
    Eur J Endocrinol; 2010 Sep; 163(3):377-82. PubMed ID: 20530552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucocorticoid induced adrenal insufficiency is common in steroid treated glomerular diseases - proposed strategy for screening and management.
    Karangizi AHK; Al-Shaghana M; Logan S; Criseno S; Webster R; Boelaert K; Hewins P; Harper L
    BMC Nephrol; 2019 May; 20(1):154. PubMed ID: 31060510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective evaluation of a week one overnight metyrapone test with subsequent dynamic assessments of hypothalamic-pituitary-adrenal axis function after pituitary surgery.
    English K; Inder WJ; Weedon Z; Dimeski G; Sorbello J; Russell AW; Duncan EL; Cuneo R
    Clin Endocrinol (Oxf); 2017 Jul; 87(1):35-43. PubMed ID: 28329436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of sampling times and serum cortisol cut-off concentrations on the routine assessment of adrenal function using the standard cosyntropin test in an academic hospital from Spain: a retrospective chart review.
    Ortiz-Flores AE; Santacruz E; Jiménez-Mendiguchia L; García-Cano A; Nattero-Chávez L; Escobar-Morreale HF; Luque-Ramírez M
    BMJ Open; 2018 May; 8(5):e019273. PubMed ID: 29730618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The one microgram adrenocorticotropin test in the assessment of hypothalamic-pituitary-adrenal function.
    Ambrosi B; Barbetta L; Re T; Passini E; Faglia G
    Eur J Endocrinol; 1998 Dec; 139(6):575-9. PubMed ID: 9916859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of the 1 μg short synacthen test: an assessment of morning cortisol cut-off values and other predictors.
    Perton FT; Mijnhout GS; Kollen BJ; Rondeel JM; Franken AA; Groeneveld PH
    Neth J Med; 2017 Jan; 75(1):14-20. PubMed ID: 28124663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Random postoperative day-3 cortisol concentration as a predictor of hypothalamic-pituitary-adrenal axis integrity after transsphenoidal surgery.
    Khan MI; Habra MA; McCutcheon IE; Nogueras-González GM; Devin JK; Busaidy NL; Levine NB; Lindstrom W; Kagan D; Jimenez C; Waguespack SG
    Endocr Pract; 2011; 17(5):717-26. PubMed ID: 21454228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Classification criteria for distinguishing cortisol responders from nonresponders to psychosocial stress: evaluation of salivary cortisol pulse detection in panel designs.
    Miller R; Plessow F; Kirschbaum C; Stalder T
    Psychosom Med; 2013; 75(9):832-40. PubMed ID: 24184845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Which patients benefit from provocative adrenal testing after transsphenoidal pituitary surgery?
    Auchus RJ; Shewbridge RK; Shepherd MD
    Clin Endocrinol (Oxf); 1997 Jan; 46(1):21-7. PubMed ID: 9059554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the hypothalamo-pituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor.
    Schmiegelow M; Feldt-Rasmussen U; Rasmussen AK; Lange M; Poulsen HS; Müller J
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3149-54. PubMed ID: 12843158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.